Literature DB >> 18451639

Association between polymorphisms in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) on chromosome 8p and schizophrenia.

Falk W Lohoff1, Andrew E Weller, Paul J Bloch, Russell J Buono, Glenn A Doyle, Thomas N Ferraro, Wade H Berrettini.   

Abstract

Linkage studies have suggested a susceptibility locus for schizophrenia (SZ) exists on chromosome 8p21-22. The vesicular monoamine transporter 1 gene (VMAT1), also known as SLC18A1, maps to this SZ susceptibility locus. Vesicular monoamine transporters are involved in the presynaptic vesicular packaging of monoamine neurotransmitters, which have been postulated to play a role in the etiology of SZ. Variations in the VMAT1 gene might affect transporter function and/or expression, and might be involved in the etiology of SZ. Genotypes of 62 patients with SZ and 188 control subjects were obtained for 4 missense single nucleotide polymorphisms (Thr4Pro, Thr98Ser, Thr136Ile, Val392Leu) and 2 noncoding single nucleotide polymorphisms (rs988713, rs2279709). All cases and controls were of European descent. The frequency of the minor allele of the Thr4Pro polymorphism was significantly increased in SZ patients when compared to controls (p = 0.0140; d.f. = 1; OR = 1.69; 95% CI = 1.11-2.57). Assuming a recessive mode of inheritance, the frequency of homozygote 4Pro carriers was significantly increased in the SZ patients when compared to controls (24 vs. 8%, respectively; p = 0.0006; d.f. = 1; OR = 3.74; 95% CI = 1.703-8.21). Haplotype analysis showed nominal significance for an individual risk haplotype (p = 0.013); however, after permutation correction, the global p value did not attain a statistically significant level (p = 0.07). Results suggest that variations in the VMAT1 gene may confer susceptibility to SZ in patients of European descent. Further studies are necessary to confirm this effect, and to elucidate the role of VMAT1 in central nervous system physiology and possible involvement in the genetic origins of SZ. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451639     DOI: 10.1159/000129668

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  19 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

3.  Association Study of VMAT1 Polymorphisms and Suicide Behavior.

Authors:  Arezou Sayad; Rezvan Noroozi; Zahra Khodamoradi; Mir Davood Omrani; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2018-03-14       Impact factor: 3.444

Review 4.  Monoamine transporters: vulnerable and vital doorkeepers.

Authors:  Zhicheng Lin; Juan J Canales; Thröstur Björgvinsson; Morgane Thomsen; Hong Qu; Qing-Rong Liu; Gonzalo E Torres; S Barak Caine
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 5.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

Review 6.  Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.

Authors:  Kandatege Wimalasena
Journal:  Med Res Rev       Date:  2010-02-04       Impact factor: 12.944

7.  VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

Authors:  P K Multani; R Hodge; M A Estévez; T Abel; H Kung; M Alter; B Brookshire; I Lucki; A H Nall; K Talbot; G A Doyle; F W Lohoff
Journal:  Neuroscience       Date:  2012-11-29       Impact factor: 3.590

8.  Resting-state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence.

Authors:  Xi Zhu; Nisha Dutta; Sarah G Helton; Melanie Schwandt; Jia Yan; Colin A Hodgkinson; Carlos R Cortes; Mike Kerich; Samuel Hall; Hui Sun; Monte Phillips; Reza Momenan; Falk W Lohoff
Journal:  Hum Brain Mapp       Date:  2015-09-14       Impact factor: 5.038

9.  Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophrenia.

Authors:  Rui Zhang; Shemin Lu; Liesu Meng; Zixin Min; Juan Tian; Robert K Valenzuela; Tingwei Guo; Lifang Tian; Wenxiang Zhao; Jie Ma
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

10.  An Integrative Bayesian Modeling Approach to Imaging Genetics.

Authors:  Francesco C Stingo; Michele Guindani; Marina Vannucci; Vince D Calhoun
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.